XSS in Myapnea

CVE-2022-4731

A vulnerability, which was classified as problematic, was found in myapnea up to 29.0.x. Affected is an unknown function of the component Title Handler. The manipulation leads to cross site scripting. It is possible to launch the attack remotely. Upgrading to version 29.1.0 is able to address this issue. The name of the patch is 99934258530d761bd5d09809bfa6c14b598f8d18. It is recommended to upgrade the affected component. VDB-216750 is the identifier assigned to this vulnerability.

Vulnerability class: XSS (Cross-Site Scripting)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.

EPSS exploit prediction

EPSS: 0.005 (41.6th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 42nd percentile — 41.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-4731: held from 0.005 to 0.005.

EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-4731?
CVE-2022-4731 is a low-severity vulnerability in Myapnea, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2022-12-25.
How severe is CVE-2022-4731?
Low severity. CVSS v3 base score is 2.4 out of 10.